Fedor N. Rozov

16/10, Miklukho Maklaya St
Moscow, MOW 117997, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

An Ex Vivo Lung Histoculture Model for Studying Pulmonary Infection and Immune Response With SARS-CoV-2 as an Example of RNA Virus.

An Ex Vivo Lung Histoculture Model for Studying Pulmonary Infection and Immune Response With SARS-CoV-2 as an Example of RNA Virus.

Journal: Bio-protocol

Published: September 09, 2025

Neprilysin 2 catalyses the degradation of natriuretic peptides despite sacubitrilat Inhibition.

Neprilysin 2 catalyses the degradation of natriuretic peptides despite sacubitrilat Inhibition.

Journal: Scientific reports

Published: January 04, 2025

Cytokine production in an ex vivo model of SARS-CoV-2 lung infection.

Cytokine production in an ex vivo model of SARS-CoV-2 lung infection.

Journal: Frontiers in immunology

Published: June 13, 2024

The Roles of eIF4G2 in Leaky Scanning and Reinitiation on the Human Dual-Coding POLG mRNA.

The Roles of eIF4G2 in Leaky Scanning and Reinitiation on the Human Dual-Coding POLG mRNA.

Journal: International journal of molecular sciences

Published: November 03, 2023

Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment-Drug Conjugates Carrying Maytansinoids DM1 and DM4.

Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment-Drug Conjugates Carrying Maytansinoids DM1 and DM4.

Journal: Current issues in molecular biology

Published: August 28, 2023

Does the SARS-CoV-2 Spike Receptor-Binding Domain Hamper the Amyloid Transformation of Alpha-Synuclein after All?

Does the SARS-CoV-2 Spike Receptor-Binding Domain Hamper the Amyloid Transformation of Alpha-Synuclein after All?

Journal: Biomedicines

Published: December 21, 2022

Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells.

Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells.

Journal: International journal of molecular sciences

Published: November 29, 2022

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.

Journal: Journal for immunotherapy of cancer

Published: June 01, 2022

Unusually efficient CUG initiation of an overlapping reading frame in POLG mRNA yields novel protein POLGARF.

Unusually efficient CUG initiation of an overlapping reading frame in POLG mRNA yields novel protein POLGARF.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 22, 2020

CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure.

CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure.

Journal: ESC heart failure

Published: July 17, 2019

Optimized dual assay for the transgenes selection and screening in CHO cell line development for recombinant protein production.

Optimized dual assay for the transgenes selection and screening in CHO cell line development for recombinant protein production.

Journal: Biotechnology letters

Published: February 28, 2019

Glycosylated and non-glycosylated NT-IGFBP-4 in circulation of acute coronary syndrome patients.

Glycosylated and non-glycosylated NT-IGFBP-4 in circulation of acute coronary syndrome patients.

Journal: Clinical biochemistry

Published: July 24, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026